Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients
Stopped early · Not applicable
Conditions studied: Liver Transplantation, Metabolic Syndrome X, Obesity
In brief
Many metabolic complications can develop after liver transplant including: diabetes, high blood pressure, obesity, heart attacks and stroke. The goal of this study is to look at the safety and effect of 2 well known and established diet regimens on the people who had a prior liver transplant and investigate whether it helps with the control of these comorbidities.
Key facts
- Study ID
- NCT02174783
- Run by
- The Cleveland Clinic
- People needed
- 25
- Starts
- 2014-06-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2017-03-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients > 18 years old who had a successful liver transplant at least 1 year prior to enrollment who also have a BMI>30 with previous failed attempts at weight loss via conventional methods. In addition to one of the following:
- Triglyceride (TG)>150 mg/dl or specific treatment for this lipid abnormality
- HDL <40 mg/dl in females and <50 mg/dl in males or specific treatment of this lipid abnormality
- Systolic BP >130 or diastolic BP >85 mm Hg or treatment for previously diagnosed hypertension
- Fasting plasma glucose >100 mg/dl or previously diagnosed type 12 diabetes
You may not qualify if…
- Significant behavioral issues that would interfere with compliance
- Lack of readiness to change (pre-contemplation, contemplation or preparation stages)
- Previous bariatric surgery
- Pregnant or planning to become pregnant
- History of a documented eating disorder (e.g. bulimia)
- History of kidney stones
Where it is running
- Cleveland Clinic — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.